Literature DB >> 3487616

B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide.

E M Rabin, J J Mond, J Ohara, W E Paul.   

Abstract

BSF-1 prepares resting BALB/c, DBA/2, and BDF1 B cells to enter S phase more promptly in response to subsequent culture with anti-IgM-based stimulants. It prepares DBA/2 and BDF1 B cells to respond to LPS, but its preparative effect for LPS responses of BALB/c B cells is both inconstant and meager. Preparation mediated by BSF-1 requires extended contact of B cells with the stimulant for full effect. Half-maximal preparation requires approximately 12 h of contact, as judged by delayed addition of BSF-1 or by inhibition of BSF-1 action with anti-BSF-1 mAbs. BSF-1 preparative action on resting DBA/2 B cells is mimicked by anti-Lyb-2.1 antibody. B cell blasts prepared by culture with BSF-1 and anti-IgM show modest responses to high concentrations of BSF-1; large B cells directly isolated from the spleen are not stimulated to enter S phase by BSF-1. These results lead us to conclude that BSF-1 functions principally as an activation factor for resting B cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487616      PMCID: PMC2188227          DOI: 10.1084/jem.164.2.517

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth.

Authors:  K Oliver; R J Noelle; J W Uhr; P H Krammer; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

2.  Partial biochemical characterization of IgG1-inducing factor.

Authors:  P Sideras; S Bergstedt-Lindqvist; E Severinson
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

Review 3.  T-cell-derived lymphokines that induce IgM and IgG secretion in activated murine B cells.

Authors:  E S Vitetta; K Brooks; Y W Chen; P Isakson; S Jones; J Layton; G C Mishra; E Pure; E Weiss; C Word
Journal:  Immunol Rev       Date:  1984-04       Impact factor: 12.988

4.  Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.

Authors:  R Noelle; P H Krammer; J Ohara; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

Review 6.  Growth-stimulatory actions of insulin in vitro and in vivo.

Authors:  D S Straus
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

7.  Inositol trisphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor.

Authors:  M J Berridge; J P Heslop; R F Irvine; K D Brown
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

8.  Partial purification of murine B cell stimulatory factor (BSF)-1.

Authors:  J Ohara; S Lahet; J Inman; W E Paul
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.

Authors:  C B Thompson; M E Schaefer; F D Finkelman; I Scher; J Farrar; J J Mond
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

10.  Clonal analysis of B cells induced to secrete IgG by T cell-derived lymphokine(s).

Authors:  J E Layton; E S Vitetta; J W Uhr; P H Krammer
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

3.  Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.

Authors:  J G Shields; R J Armitage; B N Jamieson; P C Beverley; R E Callard
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

Review 4.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

Review 5.  New insights into the role of cytokines in asthma.

Authors:  J C Renauld
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

6.  Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.

Authors:  W B Graninger; M Seto; B Boutain; P Goldman; S J Korsmeyer
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  B cell growth factor activity in supernatants of MRL-lpr/lpr derived T cell hybridomas.

Authors:  U Schauer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 8.  B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

Authors:  T Kishimoto
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

9.  Analysis of the B-cell growth-promoting activity of human IL-4, the co-stimulatory assay with anti-immunoglobulin antibodies. Comparison with the B-cell growth-promoting activity of other lymphokines.

Authors:  F Almerigogna; M G Giudizi; R Biagiotti; A Alessi; T Defrance; J Banchereau; M Ricci; S Romagnani
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

10.  Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression.

Authors:  J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.